Intero Biosystems wants drugmakers to test on mini human intestines, not animals

Posted
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.

Continue reading at TechCrunch »

Biotech & Health, Startups, Startup Battlefield 200, TechCrunch Disrupt